Heart healthHeart failureLiving with chronic illness

Living with and treating ATTR amyloidosis

Transthyretin amyloid cardiomyopathy is a condition that is caused by a buildup of abnormal protein deposits in the heart.

LearnHeartAmyloidosisLiving with and treating ATTR amyloidosis

Up Next

  • What does the heart look like for a person living with diabetes?

  • What is hypertrophic cardiomyopathy?

  • Challenges accessing care for heart failure

  • Understanding sodium and heart failure

  • Living with heart failure as a patient of color

  • When to call your physician while living with heart failure

  • Understanding heart failure: finding support

  • Can you really die of a broken heart?

  • How to manage heart failure medications

  • Loneliness and your heart

Up Next

  • What does the heart look like for a person living with diabetes?

  • What is hypertrophic cardiomyopathy?

  • Challenges accessing care for heart failure

  • Understanding sodium and heart failure

  • Living with heart failure as a patient of color

  • When to call your physician while living with heart failure

  • Understanding heart failure: finding support

  • Can you really die of a broken heart?

  • How to manage heart failure medications

  • Loneliness and your heart

AskMDAskMD

Concerned about your heart health?

Get instant answers from our AI health assistant

Ask Now

Recommended for you

An overview of TTR stabilizers and gene-silencing therapies for treating hereditary transthyretin (hATTR) amyloidosis.

Treatment options for HATTR amyloidosis
Article

Why caregivers for people with this heart condition need to prioritize their health, including mental health.

Being a caregiver for someone with ATTR-CM
Article

Understand the facts about this congenital heart condition.

What to know about Tetralogy of Fallot
Article

An overview of hospice care, including the benefits it can offer and basic strategies for finding hospice care.

3 questions and answers about hospice care
Article

Strategies for keeping medications and dosing schedules organized when treating congenital adrenal hyperplasia.

Managing multiple medications for treating CAH
Article
AskMDHow can I be more consistent?
AskMD by Sharecare LogoAskMD by Sharecare Logo
Privacy policyConsumer health data privacyTerms of use
Cookie policyYour privacy choices

© 2026 Sharecare, Inc.

ask-mdask-md
AskMD by Sharecare LogoAskMD by Sharecare Logo
Privacy policyConsumer health data privacyTerms of use
Cookie policyYour privacy choices

© 2026 Sharecare, Inc.